Medpace Holdings, Inc. Variable Lease, Cost
Medpace Holdings, Inc. (MEDP) reported Variable Lease, Cost of $3.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-07-23
- Medpace Holdings, Inc. variable lease, cost for the quarter ending 2026-06-30 was $3.43M, a 21.67% increase year-over-year.
- Medpace Holdings, Inc. variable lease, cost for the quarter ending 2026-03-31 was $3.39M, a 12.55% increase year-over-year.
- Medpace Holdings, Inc. variable lease, cost for the quarter ending 2025-12-31 was $3.28M, a 5.57% increase year-over-year.
- Medpace Holdings, Inc. variable lease, cost for the quarter ending 2025-09-30 was $3.28M, a 13.02% increase year-over-year.
- Medpace Holdings, Inc. variable lease, cost for fiscal 2025 was $12.39M, a 8.60% increase from fiscal 2024.
- Medpace Holdings, Inc. variable lease, cost for fiscal 2024 was $11.41M, a 20.67% increase from fiscal 2023.
- Medpace Holdings, Inc. variable lease, cost for fiscal 2023 was $9.46M, a 10.34% increase from fiscal 2022.
- Medpace Holdings, Inc. variable lease, cost for fiscal 2022 was $8.57M, a 29.30% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.43M 10-Q · filed 2026-07-23 | $6.82M 10-Q · filed 2026-07-23 | $10.10M derived: sum of 3 quarters · filed 2026-07-23 | $13.38M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $3.39M 10-Q · filed 2026-04-23 | $6.67M derived: sum of 2 quarters · filed 2026-04-23 | $9.95M derived: sum of 3 quarters · filed 2026-04-23 | $12.77M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $6.56M derived: sum of 2 quarters · filed 2026-02-10 | $9.38M derived: sum of 3 quarters · filed 2026-07-23 | $12.39M 10-K · filed 2026-02-10 |
| 2025-09-30 | $3.28M 10-Q · filed 2025-10-23 | $6.10M derived: sum of 2 quarters · filed 2026-07-23 | $9.11M 10-Q · filed 2025-10-23 | $12.22M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $2.82M 10-Q · filed 2026-07-23 | $5.83M 10-Q · filed 2026-07-23 | $8.94M derived: sum of 3 quarters · filed 2026-07-23 | $11.84M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $3.01M 10-Q · filed 2026-04-23 | $6.12M derived: sum of 2 quarters · filed 2026-04-23 | $9.02M derived: sum of 3 quarters · filed 2026-04-23 | $11.76M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $6.01M derived: sum of 2 quarters · filed 2026-02-10 | $8.74M derived: sum of 3 quarters · filed 2026-02-10 | $11.41M 10-K · filed 2026-02-10 |
| 2024-09-30 | $2.90M 10-Q · filed 2025-10-23 | $5.64M derived: sum of 2 quarters · filed 2025-10-23 | $8.30M 10-Q · filed 2025-10-23 | $11.22M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $2.73M 10-Q · filed 2025-07-22 | $5.40M 10-Q · filed 2025-07-22 | $8.31M derived: sum of 3 quarters · filed 2026-02-10 | $10.68M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $2.67M 10-Q · filed 2025-04-22 | $5.58M derived: sum of 2 quarters · filed 2026-02-10 | $7.95M derived: sum of 3 quarters · filed 2026-02-10 | $9.78M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $5.28M derived: sum of 2 quarters · filed 2026-02-10 | $7.12M derived: sum of 3 quarters · filed 2026-02-10 | $9.46M 10-K · filed 2026-02-10 |
| 2023-09-30 | $2.37M 10-Q · filed 2024-10-22 | $4.21M derived: sum of 2 quarters · filed 2024-10-22 | $6.54M 10-Q · filed 2024-10-22 | $8.76M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $1.83M 10-Q · filed 2024-07-23 | $4.17M 10-Q · filed 2024-07-23 | $6.39M derived: sum of 3 quarters · filed 2025-02-11 | $8.63M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $2.34M 10-Q · filed 2024-04-23 | $4.55M derived: sum of 2 quarters · filed 2025-02-11 | $6.79M derived: sum of 3 quarters · filed 2025-02-11 | $8.89M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $4.46M derived: sum of 2 quarters · filed 2025-02-11 | $6.55M derived: sum of 3 quarters · filed 2025-02-11 | $8.57M 10-K · filed 2025-02-11 |
| 2022-09-30 | $2.24M 10-Q · filed 2023-10-24 | $4.34M derived: sum of 2 quarters · filed 2023-10-24 | $6.35M 10-Q · filed 2023-10-24 | $8.41M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $2.10M 10-Q · filed 2023-07-25 | $4.11M 10-Q · filed 2023-07-25 | $6.17M derived: sum of 3 quarters · filed 2024-02-13 | $7.92M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $2.02M 10-Q · filed 2023-04-25 | $4.08M derived: sum of 2 quarters · filed 2024-02-13 | $5.83M derived: sum of 3 quarters · filed 2024-02-13 | $6.94M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $3.81M derived: sum of 2 quarters · filed 2024-02-13 | $4.92M derived: sum of 3 quarters · filed 2024-02-13 | $6.63M 10-K · filed 2024-02-13 |
| 2021-09-30 | $1.75M 10-Q · filed 2022-10-25 | $2.86M derived: sum of 2 quarters · filed 2022-10-25 | $4.57M 10-Q · filed 2022-10-25 | $6.44M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.11M 10-Q · filed 2022-07-26 | $2.82M 10-Q · filed 2022-07-26 | $4.70M derived: sum of 3 quarters · filed 2023-02-14 | $6.08M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $1.70M 10-Q · filed 2022-04-26 | $3.58M derived: sum of 2 quarters · filed 2023-02-14 | $4.97M derived: sum of 3 quarters · filed 2023-02-14 | $6.15M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.27M derived: sum of 2 quarters · filed 2023-02-14 | $4.45M derived: sum of 3 quarters · filed 2023-02-14 | $5.33M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.39M 10-Q · filed 2021-10-26 | $2.57M derived: sum of 2 quarters · filed 2021-10-26 | $3.46M 10-Q · filed 2021-10-26 | $4.27M derived: sum of 4 quarters · filed 2021-10-26 |
| 2020-06-30 | $1.18M 10-Q · filed 2021-07-27 | $2.07M 10-Q · filed 2021-07-27 | $2.89M derived: sum of 3 quarters · filed 2021-07-27 | $3.54M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $886.00K 10-Q · filed 2021-04-27 | $1.70M derived: sum of 2 quarters · filed 2021-04-27 | $2.35M derived: sum of 3 quarters · filed 2021-04-27 | $3.10M derived: sum of 4 quarters · filed 2021-04-27 |
| 2019-12-31 | $818.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $1.47M derived: sum of 2 quarters · filed 2021-02-16 | $2.22M derived: sum of 3 quarters · filed 2021-02-16 | $2.81M 10-K · filed 2021-02-16 |
| 2019-09-30 | $649.00K 10-Q · filed 2020-10-27 | $1.40M derived: sum of 2 quarters · filed 2020-10-27 | $2.00M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $752.00K 10-Q · filed 2020-07-28 | $1.35M 10-Q · filed 2020-07-28 | ||
| 2019-03-31 | $594.00K 10-Q · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |